檢索結果 - Nilofer S. Azad
- Showing 1 - 20 results of 52
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma 由 Diane K. Reyes, Josephina A. Vossen, Ihab R. Kamel, Nilofer S. Azad, T. Wahlin, Michael Torbenson, Michael A. Choti, Jean-François H. Geschwind
出版 2009Artigo -
10
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis 由 Arsen Osipov, Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng, Elizabeth M. Jaffee, Hao Wang, Mark Yarchoan
出版 2020Revisão -
11
A randomized pilot trial of a telephone‐based couples intervention for physical intimacy and sexual concerns in colorectal cancer 由 Jennifer Barsky Reese, Laura S. Porter, Katelyn R. Regan, Francis J. Keefe, Nilofer S. Azad, Luis A. Díaz, Joseph M. Herman, Jennifer A. Haythornthwaite
出版 2014Artigo -
12
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models 由 Chaoxin Hu, Tikva Dadon, Venugopal Chenna, Shinichi Yabuuchi, Rajat Bannerji, Robert Booher, Peter R. Strack, Nilofer S. Azad, Barry D. Nelkin, Anirban Maitra
出版 2015Artigo -
13
-
14
-
15
-
16
-
17
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases 由 Georgios Karagkounis, Michael Torbenson, Hubert Darius Daniel, Nilofer S. Azad, Luis A. Díaz, Ross C. Donehower, Kenzo Hirose, Nita Ahuja, Timothy M. Pawlik, Michael A. Choti
出版 2013Artigo -
18
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma 由 Rachna T. Shroff, Mark Yarchoan, Ashley O’Connor, Denise Gallagher, Marianna Zahurak, Gary L. Rosner, Chimela Ohaji, Susan Sartorius‐Mergenthaler, Vivek Subbiah, Ralph Zinner, Nilofer S. Azad
出版 2017Artigo -
19
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours 由 Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci
出版 2016Artigo -
20
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017 由 Milind Javle, Sunyoung Lee, Nilofer S. Azad, Mitesh J. Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora A. Janjan, Shreekant Parasuraman, Tanios Bekaii‐Saab
出版 2022Artigo
相關主題
Medicine
Internal medicine
Cancer
Oncology
Cancer research
Biology
Colorectal cancer
Gene
Chemotherapy
Biochemistry
Genetics
Immunotherapy
Immunology
Gastroenterology
Immune system
Chemistry
Pharmacology
Mutation
Biomarker
KRAS
Pancreatic cancer
Clinical trial
Hepatocellular carcinoma
Immune checkpoint
Pembrolizumab
Tumor microenvironment
Adverse effect
Disease
Leukopenia
Neutropenia